131 related articles for article (PubMed ID: 20202469)
1. Development of an immunoassay for the detection of cystatin C dimers.
Hyytiä H; Ristiniemi N; Airas L; Pettersson K; Hellman J
J Immunol Methods; 2010 Apr; 355(1-2):14-20. PubMed ID: 20202469
[TBL] [Abstract][Full Text] [Related]
2. Physico-chemical properties of the N-terminally truncated L68Q cystatin C found in amyloid deposits of brain haemorrhage patients.
Gerhartz B; Abrahamson M
Biol Chem; 2002 Feb; 383(2):301-5. PubMed ID: 11934268
[TBL] [Abstract][Full Text] [Related]
3. Domain swapping in N-truncated human cystatin C.
Janowski R; Abrahamson M; Grubb A; Jaskolski M
J Mol Biol; 2004 Jul; 341(1):151-60. PubMed ID: 15312769
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid.
Perlenfein TJ; Mehlhoff JD; Murphy RM
J Biol Chem; 2017 Jul; 292(27):11485-11498. PubMed ID: 28487367
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for amyloidosis related to hereditary brain hemorrhage.
Abrahamson M
Scand J Clin Lab Invest Suppl; 1996; 226():47-56. PubMed ID: 8981667
[TBL] [Abstract][Full Text] [Related]
6. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C.
Gerhartz B; Ekiel I; Abrahamson M
Biochemistry; 1998 Dec; 37(49):17309-17. PubMed ID: 9860845
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cystatin C in cerebrospinal fluid.
Yamada T; Mukaiyama I; Miyake N; Igari J
Rinsho Byori; 2002 Jun; 50(6):613-7. PubMed ID: 12166082
[TBL] [Abstract][Full Text] [Related]
8. The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.
Maetzler W; Schmid B; Synofzik M; Schulte C; Riester K; Huber H; Brockmann K; Gasser T; Berg D; Melms A
J Alzheimers Dis; 2010; 19(3):937-42. PubMed ID: 20157249
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
[TBL] [Abstract][Full Text] [Related]
11. High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy.
Östner G; Lindström V; Postnikov AB; Solovyeva TI; Emilsson ÖI; Grubb A
Scand J Clin Lab Invest; 2011 Dec; 71(8):676-82. PubMed ID: 22017167
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of monoclonal antibody against cystatin C and establishment of its immunoassay system].
Yu Y; Yang T; Liu P; Wang N; Lu Y; Huang Y; Shen P
Wei Sheng Yan Jiu; 2017 Jul; 46(4):628-632. PubMed ID: 29903187
[TBL] [Abstract][Full Text] [Related]
13. The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids.
Bjarnadottir M; Nilsson C; Lindström V; Westman A; Davidsson P; Thormodsson F; Blöndal H; Gudmundsson G; Grubb A
Amyloid; 2001 Mar; 8(1):1-10. PubMed ID: 11293820
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
Seo YS; Jung ES; An H; Kim JH; Jung YK; Kim JH; Yim HJ; Yeon JE; Byun KS; Kim CD; Ryu HS; Um SH
Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
[TBL] [Abstract][Full Text] [Related]
15. NMR structural studies of human cystatin C dimers and monomers.
Ekiel I; Abrahamson M; Fulton DB; Lindahl P; Storer AC; Levadoux W; Lafrance M; Labelle S; Pomerleau Y; Groleau D; LeSauteur L; Gehring K
J Mol Biol; 1997 Aug; 271(2):266-77. PubMed ID: 9268658
[TBL] [Abstract][Full Text] [Related]
16. Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
Visvardis G; Griveas I; Zilidou R; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Ginikopoulou E; Meimaridou D; Pavlitou A; Sakellariou G
Transplant Proc; 2004; 36(6):1757-9. PubMed ID: 15350470
[TBL] [Abstract][Full Text] [Related]
17. Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: why is the L68Q variant amyloidogenic?
Rodziewicz-Motowidło S; Wahlbom M; Wang X; Lagiewka J; Janowski R; Jaskólski M; Grubb A; Grzonka Z
J Struct Biol; 2006 Apr; 154(1):68-78. PubMed ID: 16446102
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C in cerebrospinal fluid and multiple sclerosis.
Hansson SF; Simonsen AH; Zetterberg H; Andersen O; Haghighi S; Fagerberg I; Andréasson U; Westman-Brinkmalm A; Wallin A; Rüetschi U; Blennow K
Ann Neurol; 2007 Aug; 62(2):193-6; discussion 205. PubMed ID: 16900522
[TBL] [Abstract][Full Text] [Related]
19. Adult cystatin C reference intervals determined by nephelometric immunoassay.
Croda-Todd MT; Soto-Montano XJ; Hernández-Cancino PA; Juárez-Aguilar E
Clin Biochem; 2007 Sep; 40(13-14):1084-7. PubMed ID: 17624320
[TBL] [Abstract][Full Text] [Related]
20. Determination of cerebrospinal fluid cystatin C on Architect ci8200.
Ndjole AM; Bodolea C; Nilsen T; Gordh T; Flodin M; Larsson A
J Immunol Methods; 2010 Aug; 360(1-2):84-8. PubMed ID: 20598708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
